Bosulif
Brand for: Bosutinib
My Prescription
Payment
Select pharmacy
$2,731.82
Print or send this coupon to your phone
AlbertsonsPowered byAbout Bosulif
Drug Details
Bosutinib, marketed as Bosulif, is a medication used to treat adults and children with a specific type of blood cancer known as Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML). This drug functions as a tyrosine kinase inhibitor by blocking the BCR-ABL tyrosine kinase protein, which is found on cancer cells. By inhibiting this protein, Bosulif effectively slows down or halts the growth and spread of cancer cells. It is available in tablet form and is taken orally once daily. While Bosulif is a recommended treatment option for Ph+ CML, it may cause side effects such as diarrhea and other gastrointestinal issues. Always discuss with your healthcare provider before starting any new medication.
Bosulif (Bosutinib) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 100MG | 120 Tablets | $4,012.66 | $33.44 |
| 400MG | 30 Tablets | $4,284.98 | $142.83 |
| 500MG | 30 Tablets | $4,012.66 | $133.76 |
Bosulif FAQs
Bosulif is used to treat certain types of chronic myelogenous leukemia (CML), which is a cancer of the white blood cells. It is typically prescribed for patients who have been diagnosed with Philadelphia chromosome-positive CML.
Yes, Bosulif (bosutinib) is considered a type of chemotherapy. It is a tyrosine kinase inhibitor used in the treatment of certain types of chronic myeloid leukemia (CML).
Long-term effects of Bosulif (bosutinib) can include potential liver toxicity, gastrointestinal issues such as diarrhea, and hematologic effects like thrombocytopenia, anemia, and neutropenia. Patients may also experience fluid retention, which can lead to edema or pleural effusion. Monitoring for cardiac effects, such as arrhythmias, is also important. Regular follow-up with healthcare providers is essential to manage and mitigate these effects.
The cost of Bosulif can vary depending on factors such as the pharmacy, location, insurance coverage, and dosage. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.
Bosulif, a medication used to treat certain types of leukemia, may be covered under Medicare Part D, which is the prescription drug plan. Coverage can vary depending on the specific Part D plan, so it is important for individuals to check with their plan provider to confirm if Bosulif is included in their formulary and to understand any associated costs or requirements.